Cynata Therapeutics Ltd
ASX:CYP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
Impinj Inc
NASDAQ:PI
|
US |
|
E
|
Extra Space Storage Inc
F:FG8
|
US |
|
Chongqing Construction Engineering Group Co Ltd
SSE:600939
|
CN |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
ISS A/S
CSE:ISS
|
DK |
|
I
|
Indika Energy Tbk PT
XMUN:I41
|
ID |
|
BWR Exploration Inc
XTSX:BWR
|
CA |
|
Endesa SA
OTC:ELEZF
|
ES |
|
Y
|
Yamato Corp
TSE:1967
|
JP |
|
K
|
Kellogg Co
F:KEL
|
US |
|
Akora Resources Ltd
ASX:AKO
|
AU |
|
Nova Ltd
NASDAQ:NVMI
|
IL |
|
T
|
TriMas Corp
F:MQ1
|
US |
|
D
|
Deutsche Post AG
F:DPW
|
DE |
|
C
|
China International Capital Corp Ltd
F:CIM
|
CN |
|
ProPetro Holding Corp
F:2PG
|
US |
|
A
|
Autoliv Inc
SWB:LIV
|
SE |
|
Kelt Exploration Ltd
TSX:KEL
|
CA |
|
Saferoads Holdings Ltd
ASX:SRH
|
AU |
|
Newell Brands Inc
NASDAQ:NWL
|
US |
|
S
|
Southern Co
XMUN:SOT
|
US |
|
G
|
Glencore PLC
BMV:GLENN
|
CH |
|
A
|
Automatic Bank Services Ltd
TASE:SHVA
|
IL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CYP's stock price target?
Not Available
CYP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cynata Therapeutics Ltd?
Projected CAGR
123%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 123%.